A novel link between the proteasome pathway and the signal transduction pathway of the Bone Morphogenetic Proteins (BMPs)

BMC Cell Biology

Volumn 3, Issue , 2002, Pages

  Lin, Yin ^d   Martin, Jennifer ^a,e,f   Gruendler, Cornelia ^a,e,f   Farley, Jennifer ^a,e,f   Meng, Xianwang ^a,e,f   Li, Bi Yu ^a,e,f   Lechleider, Robert ^c   Huff, Carla ^c   Kim, Richard H ^c   Grasser, William ^b   Paralkar, Vishwas ^b   Wang, Tongwen ^a,e,f  

^a BENAROYA RESEARCH INSTITUTE   (United States)

^b PFIZER INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIZYME; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR; HISTONE ACETYLTRANSFERASE PCAF; PROTEASOME; PROTEIN P300; SMAD1 PROTEIN; SMAD4 PROTEIN; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN RECEPTOR 1; CARRIER PROTEIN; CYSTEINE PROTEINASE; DNA BINDING PROTEIN; GROWTH FACTOR RECEPTOR; MULTIENZYME COMPLEX; PROTEIN PRECURSOR; PROTEIN SERINE THREONINE KINASE; PSMB4 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMAD PROTEIN; SMAD1 PROTEIN, HUMAN; SNIP1 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME SUBUNIT; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE REPRESSION; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PROTEIN ASSEMBLY; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; ANIMAL; CELL CULTURE; CELL LINE; CELL STRAIN COS1; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MUTATION; PROTEIN BINDING; SERODIAGNOSIS; TWO HYBRID SYSTEM; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE I; BONE MORPHOGENETIC PROTEINS; CARRIER PROTEINS; CELL LINE; COS CELLS; CYSTEINE ENDOPEPTIDASES; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIENZYME COMPLEXES; MUTATION; PRECIPITIN TESTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; PROTEIN PRECURSORS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, GROWTH FACTOR; SIGNAL TRANSDUCTION; SMAD PROTEINS; SMAD1 PROTEIN; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 2342666616     PISSN: 14712121     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2121-3-15     Document Type: Article

References (55)

1. Harland RM: The transforming growth factor beta family and induction of the vertebrate mesoderm: bone morphogenetic proteins are ventral inducers [comment]. Proc Natl Acad Sci U S A 1994, 91:10243-10246
2. Hogan BL: Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev 1996, 10:1580-1594
3. Kingsley DM: The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev 1994, 8:133-146
4. Reddi AH: Regulation of cartilage and bone differentiation by bone morphogenetic proteins. Curr Opin Cell Biol 1992, 4:850-855
5. Kawabata M, Imamura T, Miyazono K: Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 1998, 9:49-61
6. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791
7. Wrana JL: Regulation of Smad activity. Cell 2000, 100:189-192
8. Zhang Y, Derynck R: Regulation of Smad signalling by protein associations and signalling crosstalk. Trends Cell Biol 1999, 9:274-279
9. Kawabata M, Inoue H, Hanyu A, Imamura T, Miyazono K: Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J 1998, 17:4056-4065
10. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 2000, 14:627-644
11. Attisano L, Wrana JL: Smads as transcriptional co-modulators. Curr Opin Cell Biol 2000, 12:235-243
12. Kim J, Johnson K, Chen HJ, Carroll S, Laughon A: Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 1997, 388:304-308
13. de Caestecker MP, Yahata T, Wang D, Parks WT, Huang S, Hill CS, et al: The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J Biol Chem 2000, 275:2115-2122
14. Verschueren K, Remacle JE, Collart C, Kraft H, Baker BS, Tylzanowski P, et al: SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5'-CACCT sequences in candidate target genes. J Biol Chem 1999, 274:20489-20498
15. Shi X, Yang X, Chen D, Chang Z, Cao X: Smad1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem 1999, 274:13711-13717
16. Nakashima K, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, Kawabata M, et al: Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300 [see comments]. Science 1999, 284:479-482
17. Coux O, Tanaka K, Goldberg AL: Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996, 65:801-847
18. Hayashi S, Murakami Y, Matsufuji S: Ornithine decarboxylase antizyme: a novel type of regulatory protein. Trends Biochem Sci 1996, 21:27-30
19. Chen P, Hochstrasser M: Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 1996, 86:961-972
20. Pickart CM: Targeting of substrates to the 26S proteasome. FASEB J 1997, 11:1055-1066
21. Tanaka K, Chiba T: The proteasome: a protein-destroying machine. Genes Cells 1998, 3:499-510
22. Cruz M, Nandi D, Hendil KB, Monaco JJ: Cloning and characterization of mouse Lmp3 cDNA, encoding a proteasome beta subunit. Gene 1997, 190:251-256
23. Kopp F, Kristensen P, Hendil KB, Johnsen A, Sobek A, Dahlmann B: The human proteasome subunit HsN3 is located in the inner rings of the complex dimer. J Mol Biol 1995, 248:264-272
24. Thomson S, Rivett AJ: Processing of N3, a mammalian proteasome beta-type subunit. Biochem J 1996, 315(Pt 3):733-738
25. Kim RH, Wang D, Tsang M, Martin J, Huff C, de Caestecker MP, et al: A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-beta signal transduction. Genes Dev 2000, 14:1605-1616
26. Brent R, Finley RL Jr: Understanding gene and allele function with two-hybrid methods. Annu Rev Genet 1997, 31:663-704
27. Zervos AS, Gyuris J, Brent R: Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites [published erratum appears in Cell 1994 Oct 21;79(2):following 388]. Cell 1993, 72:223-232
28. Ray R, Miller DM: Cloning and characterization of a human cmyc promoter-binding protein. Mol Cell Biol 1991, 11:2154-2161
29. Gross B, Gaestel M, Bohm H, Bielka H: cDNA sequence coding for a translationally controlled human tumor protein. Nucleic Acids Res 1989, 17:8367
30. Prosperi MT, Ferbus D, Karczinski I, Goubin G: A human cDNA corresponding to a gene overexpressed during cell proliferation encodes a product sharing homology with amoebic and bacterial proteins. J Biol Chem 1993, 268:11050-11056
31. Parks WT, Frank DB, Huff C, Renfrew HC, Martin J, Meng X, et al: Sorting Nexin 6, a Novel SNX, Interacts with the Transforming Growth Factor-beta Family of Receptor Serine-Threonine Kinases. J Biol Chem 2001, 276:19332-19339
32. Rousset R, Desbois C, Bantignies F, Jalinot P: Effects on NF-kappa B1/p105 processing of the interaction between the HTLV-1 transactivator Tax and the proteasome. Nature 1996, 381:328-331
33. Frentzel S, Pesold-Hurt B, Seelig A, Kloetzel PM: 20 S proteasomes are assembled via distinct precursor complexes. Processing of LMP2 and LMP7 proproteins takes place in 13-16 S preproteasome complexes. J Mol Biol 1994, 236:975-981
34. Nandi D, Woodward E, Ginsburg DB, Monaco JJ: Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits. EMBO J 1997, 16:5363-5375
35. Schmidt M, Schmidtke G, Kloetzel PM: Structure and structure formation of the 20S proteasome. Mol Biol Rep 1997, 24:103-112
36. Schmidtke G, Schmidt M, Kloetzel PM: Maturation of mammalian 20 S proteasome: purification and characterization of 13 S and 16 S proteasome precursor complexes. J Mol Biol 1997, 268:95-106
37. Kruger E, Kloetzel P, Enenkel C: 20S proteasome biogenesis. Biochimie 2001, 83:289-293
38. Groll M, Ditzel L, Lowe J, Stock D, Bochtler M, Bartunik HD, et al: Structure of 20S proteasome from yeast at 2.4 A resolution [see comments]. Nature 1997, 386:463-471
39. Gruendler C, Lin Y, Farley J, Wang T: Proteasomal degradation of Smad1 induced by bone morphogenetic proteins. J Biol Chem 2001, 276:46533-46543
40. Hoodless PA, Haerry T, Abdollah S, Stapleton M, O'Connor MB, Attisano L, et al: MADR1, a MAD-related protein that functions in BMP2 signaling pathways. Cell 1996, 85:489-500
41. Macias-Silva M, Hoodless PA, Tang SJ, Buchwald M, Wrana JL: Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J Biol Chem 1998, 273:25628-25636
42. Liu F, Hata A, Baker JC, Doody J, Carcamo J, Harland RM, et al: A human Mad protein acting as a BMP-regulated transcriptional activator [see comments]. Nature 1996, 381:620-623
43. Hayashi H, Abdollah S, Qiu Y, Cai J, Xu YY, Grinnell BW, et al: The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 1997, 89:1165-1173
44. Guo X, Lin Y, Horbinski C, Drahushuk KM, Kim I-J, Kaplan PL, Lein P, Wang T, Higgins D: J Neurobiology 2001, 48:120-130
45. Matsufuji S, Inazawa J, Hayashi T, Miyazaki Y, Ichiba T, Furusaka A, et al: Assignment of the human antizyme gene (OAZ) to chromosome 19p13.3 by fluorescence in situ hybridization. Genomics 1996, 38:102-104
46. Ramos PC, Hockendorff J, Johnson ES, Varshavsky A, Dohmen RJ: Ump1p is required for proper maturation of the 20S proteasome and becomes its substrate upon completion of the assembly. Cell 1998, 92:489-499
47. Zhu H, Kavsak P, Abdollah S, Wrana JL, Thomsen GH: A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 1999, 400:687-693
48. Stroschein SL, Wang W, Zhou S, Zhou Q, Luo K: Negative feedback regulation of TGF-beta signaling by the SnoN oncoprotein [see comments]. Science 1999, 286:771-774
49. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA: SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci U S A 1999, 96:12442-12447
50. Lo RS, Massague J: Ubiquitin-dependent degradation of TGFbeta-activated Smad2. Nat Cell Biol 1999, 1:472-478
51. Ebisawa T, Fukuchi M, Murakami G, Chiba T, Tanaka K, Imamura T, et al: Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J Biol Chem 2001, 276:12477-12480
52. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, et al: Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol Cell 2000, 6:1365-1375
53. Zhang Y, Chang C, Gehling DJ, Hemmati-Brivanlou A, Derynck R: Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligase. Proc Natl Acad Sci U S A 2001, 98:974-979
54. Lin X, Liang M, Feng XH: Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J Biol Chem 2000, 275:36818-36822
55. Ausubel FM: In Current Protocols in Molecular Biology. (Edited by: Janssen K) New York: John Wiley & Sons; 1994, 1-20